Comera Life Sciences Holdings, Inc. - CMRA
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Corient Private Wealth LLC | History | New | 493,692 | 123 | 0.0% | — | 1 | +493,692 | New | Q3 2023 | Nov 03, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | History | Added to | 70,212 | 22 | 0.0% | 0.0% | 2 | +10,204 | 17.0% | Q3 2023 | Nov 13, 2023 |
| HighTower Advisors, LLC | History | No change | 47,600 | 14 | 0.0% | 0.0% | 3 | 0 | 0.0% | Q3 2023 | Nov 08, 2023 |
| VANGUARD GROUP INC | History | No change | 44,098 | 12 | 0.0% | 0.0% | 4 | 0 | 0.0% | Q3 2023 | Dec 18, 2023 |
| STATE STREET CORP | History | No change | 29,600 | 9 | 0.0% | 0.0% | 5 | 0 | 0.0% | Q3 2023 | Nov 14, 2023 |
| CITADEL ADVISORS LLC | History | New | 17,458 | 5 | 0.0% | — | 6 | +17,458 | New | Q3 2023 | Nov 14, 2023 |
| UBS Group AG | History | Added to | 8,017 | 2 | 0.0% | — | 8 | +6,366 | 385.58% | Q3 2023 | Nov 09, 2023 |
| Tower Research Capital LLC (TRC) | History | Reduced | 7,338 | 2 | 0.0% | 0.0% | 7 | -24 | -0.33% | Q3 2023 | Nov 14, 2023 |
| OSAIC HOLDINGS, INC. | History | Reduced | 3,600 | 1 | 0.0% | 0.0% | 9 | -15,150 | -80.8% | Q3 2023 | Nov 13, 2023 |
| JPMORGAN CHASE & CO | History | New | 13 | 0 | — | — | — | +13 | New | Q3 2023 | Nov 14, 2023 |
| WELLS FARGO & COMPANY/MN | History | Reduced | 85 | 0 | — | — | — | -11 | -11.46% | Q3 2023 | Nov 13, 2023 |
| MORGAN STANLEY | History | No change | 2,292 | 0 | — | 0.0% | — | 0 | 0.0% | Q3 2023 | Nov 15, 2023 |
| WOLVERINE ASSET MANAGEMENT LLC | History | No change | 652 | 0 | — | — | — | 0 | 0.0% | Q3 2023 | Nov 13, 2023 |